Agoracom Blog Home

Posts Tagged ‘Predictmedix’

Predictmedix AI Unveils Cutting-Edge Advances in Health Screening Technology

Posted by Brittany McNabb at 9:15 AM on Thursday, January 11th, 2024

Revolutionizing Health Assessments and Pioneering Breakthroughs in Personalized Healthcare

In a groundbreaking move, Predictmedix AI Inc. takes a giant leap forward in the realm of rapid health screening solutions. The company, known for its cutting-edge artificial intelligence (AI) technologies, proudly announces a series of technological advancements within its Safe Entry Station (SES) platform. These innovations not only reinforce Predictmedix AI’s commitment to pioneering advancements in health and safety but also set the stage for anticipated commercial success, solidifying its position as an industry leader.

Background and Context

Delving into the company’s history, Predictmedix AI has consistently strived for innovation in health and safety applications. The Safe Entry Station, powered by proprietary AI, has been at the forefront of reshaping health assessments globally. With a history of groundbreaking achievements, Predictmedix AI is now pushing the boundaries even further.

Key Highlights and Advantages

  • Emotional State Identification: SES now goes beyond conventional health parameters by accurately identifying emotions, introducing a new dimension to health assessments. Happiness, neutrality, surprise, sadness, anger, fear, and disgust can now be discerned, enhancing the understanding of an individual’s mental well-being.
  • PRQ Assessment: Pulse Respiration Quotient (PRQ) integration provides a comprehensive health evaluation, reflecting the intricate interplay between cardiac and respiratory activities. This nuanced metric offers insights into the efficiency of heart and lung functions, contributing to a more thorough health assessment.
  • Stress Monitoring: The successful deployment of stress monitoring code adds another layer of understanding, enabling SES to identify stress or stress-free states during scanning. This valuable insight into mental well-being contributes to a holistic health evaluation.
  • Face Verification Accuracy: Rigorous testing on over 500 subjects showcases the robustness of face verification technology, achieving an impressive accuracy rate of over 99%. This ensures reliable identity verification, a critical aspect of health and safety applications.

Potential Impact and Significance

These technological strides significantly expand the capabilities of Safe Entry Stations, positioning Predictmedix AI as a frontrunner in innovative health and safety solutions. The integration of emotional state identification, PRQ assessment, stress monitoring, and highly accurate face verification enhances the potential applications across diverse industries.

Expert Opinions and Analysis

Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix AI, emphasizes, “These technical strides reinforce our position at the forefront of innovative health and safety solutions.” The endorsements from industry experts echo the transformative impact these advancements could have on health assessments globally.

Challenges and Considerations

While the advancements showcase the immense potential, challenges such as widespread adoption and integration into various healthcare settings need to be addressed. Predictmedix AI’s commitment to addressing these challenges through strategic planning and collaboration is highlighted.

Conclusion

In summary, Predictmedix AI’s unveiling of cutting-edge advances in health screening technology marks a pivotal moment in the company’s journey. The significance of these innovations extends beyond health assessments, promising a future where personalized healthcare and continuous health monitoring become more accessible.

View original source: https://predictmedix.com/predictmedix-ai-unveils-technological-advances-including-publishing-of-peer-reviewed-paper/

Predictmedix AI: Transforming Healthcare Beyond Screening

Posted by Brittany McNabb at 5:18 PM on Monday, January 8th, 2024

In the ever-evolving landscape of healthcare, one company stands out for its commitment to revolutionizing the way we approach health screening and patient care. Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) is not just a player in the field; it’s a catalyst for change, leveraging the power of artificial intelligence (AI) to transform healthcare practices globally.

Unraveling the Predictmedix Story

At its core, Predictmedix is a trailblazer in rapid health screening solutions, driven by proprietary AI technology. The company’s journey has been marked by a relentless pursuit of innovation and a commitment to addressing critical needs in the healthcare sector.

The Safe Entry Stations Revolution

A centerpiece of Predictmedix’s impact lies in its Safe Entry Stations, a marvel powered by multispectral cameras and AI algorithms. These stations go beyond conventional health screenings, predicting a spectrum of health issues, from physiological vital parameters to impairment by drugs or alcohol, fatigue, and even various mental illnesses.

Recent Technological Leap: Facial Recognition Integration

In a recent announcement, Predictmedix took a giant leap forward by integrating advanced facial recognition technology into its Safe Entry Stations. This strategic move enhances security, enables contactless access, and ensures a user-friendly experience. The real-time identification capabilities of this technology have far-reaching implications, not just in healthcare but across diverse industries.

The Mental Health Milestone

Beyond the technological prowess, Predictmedix has achieved groundbreaking milestones in mental health detection and analysis. With an estimated 5% of adults worldwide grappling with depression, Predictmedix’s AI algorithms now detect signs of depression and anxiety, offering a beacon of hope in addressing the global mental health crisis.

Strategic Partnerships and Endorsements

Predictmedix has garnered endorsements from esteemed institutions like the University of Raharja in Indonesia, where a clinical validation showcased 95% accuracy in vital sign detection. Such collaborations not only validate Predictmedix’s technology but also open doors to broader applications globally.

Looking Ahead: A Glimpse into the Future

As Predictmedix continues to push the boundaries of what’s possible in healthcare technology, its focus on personalized patient experiences, medication management, and applications in clinical trials positions it as a driving force in shaping the future of healthcare.

Navigating Challenges with Integrity

In the journey of innovation, Predictmedix acknowledges challenges, particularly concerning privacy and data security. However, the company’s commitment to robust safeguards and adherence to regulatory standards instills confidence in stakeholders.

Closing Thoughts: Beyond the Headlines

Predictmedix is not just a company making headlines; it’s an embodiment of progress in the healthcare sector. For investors seeking opportunities aligned with technological advancements, social impact, and the future of healthcare, Predictmedix is a name worth exploring.

YOUR NEXT STEPS

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

DISCLAIMER AND DISCLOSURE

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected]

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Predictmedix AI Advances Mental Health Detection and Analysis

Posted by Brittany McNabb at 11:02 AM on Tuesday, December 5th, 2023

 

Revolutionizing Healthcare with Groundbreaking AI Achievements

In the fast-evolving landscape of health technology, Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) continues to stand at the forefront, making waves with groundbreaking achievements in mental health detection and analysis. As a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), the company has reached significant milestones that promise transformative impacts on global mental health.

Background and Context

In an era where mental health concerns are reaching alarming proportions, Predictmedix AI stands as a beacon of innovation. With a mission to advance healthcare through cutting-edge AI solutions, the company has a history of pushing boundaries and challenging the status quo. The latest breakthroughs in mental health detection align seamlessly with Predictmedix AI’s commitment to proactive healthcare solutions.

Key Highlights and Advantages

Predictmedix AI has achieved unprecedented functionality in mental health detection and analysis, specifically targeting depression and anxiety. These advancements are underpinned by state-of-the-art AI algorithms, positioning the company as a trailblazer in addressing the critical need for early identification and intervention in mental health.

The company has successfully implemented functionalities for mood and emotion analysis, offering a comprehensive understanding of an individual’s mental well-being. This goes beyond traditional diagnostics, providing nuanced insights that can significantly impact mental health outcomes.

In a significant milestone, Predictmedix AI proudly announces the completion of over 250,000 individual scans. This accomplishment not only underscores the effectiveness and reliability of the AI-powered Safe Entry Station technology but also solidifies the company’s position as a leader in the evolving landscape of health and safety applications.

Potential Impact and Significance

The implications of Predictmedix AI’s achievements are profound. In a world where mental health challenges are often underestimated and overlooked, the company’s technology offers a lifeline. By focusing on early detection and nuanced analysis, Predictmedix AI aims to reshape outcomes and provide much-needed support to individuals grappling with mental health issues.

Expert Opinions and Analysis

Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix AI, commented on these achievements, stating, “Our advancements in developing advanced functionalities for depression and anxiety detection, coupled with mood and emotion analysis, mark a significant step forward in leveraging AI for mental health. This milestone isn’t merely a numerical achievement; it echoes the lives touched and the potential for early interventions that can reshape the course of mental health outcomes.”

Challenges and Considerations

While Predictmedix AI celebrates these achievements, challenges in the mental health landscape remain. Stigma, accessibility, and awareness are ongoing considerations. The company acknowledges these challenges and is committed to contributing to the broader conversation on mental health.

Conclusion

In conclusion, Predictmedix AI’s strides in mental health detection and analysis represent a paradigm shift in the intersection of healthcare and artificial intelligence. With over 250,000 scans completed, the real-world impact of this technology is undeniable. As machine learning accuracy continues to improve, Predictmedix AI is dedicated to advancing innovation in health and safety applications for the benefit of individuals and communities. This achievement is not just about technology; it’s about the lives touched and the potential for a brighter, healthier future.

View original release: https://www.accesswire.com/813262/predictmedix-ai-achieves-significant-milestones-in-mental-health-detection-and-analysis

Predictmedix AI Revolutionizes Health Screening with 95% Accuracy: A Breakthrough Clinical Validation

Posted by Brittany McNabb at 7:54 AM on Tuesday, November 14th, 2023

In a groundbreaking move toward advancing health screening technology, Predictmedix AI Inc. has achieved a significant milestone with a successful clinical validation at the University of Raharja, Indonesia. This accomplishment, marked by a remarkable 95% accuracy in vital sign detection, underscores Predictmedix’s commitment to prioritizing well-being through cutting-edge artificial intelligence (AI).

Predictmedix AI, a leader in rapid health screening solutions, has a rich history of leveraging AI to redefine safety culture and enhance the physical and mental well-being of individuals. This collaborative effort with the University of Raharja is a testament to the company’s dedication to innovation and its mission to foster a “Fit for Duty” culture.

Key Highlights and Advantages:

The clinical study aimed to develop non-invasive AI-based software capturing vital signs, including heart rate, respiration rate, height, body temperature, and blood pressure.

Notably, the solution prioritizes privacy by avoiding recognizable facial images while ensuring accurate and consistent vital sign readings.

Key features include face detection, SOP violation detection, body temperature detection, heart rate monitoring, respiration rate monitoring, SpO2 measurement, height assessment, and blood pressure measurement.

Potential Impact and Significance:

The clinical validation, with an impressive 95% accuracy across critical parameters, is a monumental achievement. Predictmedix AI’s solution holds the potential to revolutionize health screening, creating safer and more efficient workplaces globally. The iterative refinements in the AI algorithms ensure continuous improvement, with an accuracy range between 90% and 99% for all vital signs.

Expert Opinions and Analysis:

Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix AI, expressed the significance of this milestone, stating, “The accuracy and maturity of our AI solution, especially in vital sign screening, are truly rewarding. We eagerly anticipate exploring broader applications to benefit society.” Raharja University endorses Predictmedix’s Safe Entry Station solution, highlighting its effectiveness in non-invasive patient screening for various conditions.

Challenges and Considerations:

While the clinical validation marks a substantial achievement, potential challenges in adoption and implementation may arise. Predictmedix AI is well-prepared to address these challenges, ensuring the continuous refinement and reliability of their AI solution.

Predictmedix AI’s breakthrough in achieving 95% accuracy in vital sign detection heralds a new era in health screening technology. This accomplishment reinforces the company’s position as a leader in the field and sets the stage for broader applications that can benefit society at large. As Predictmedix continues to innovate, its commitment to fostering a safer and healthier global community remains unwavering.

View original release: https://predictmedix.com/predictmedix-ai-announces-successful-clinical-validation-at-the-university-of-raharja-indonesia-demonstrating-95-accuracy-in-vital-sign-detection/ 

 

Predictmedix AI Showcases Revolutionary Health and Safety Solution at D-30 Event in New Delhi

Posted by Brittany McNabb at 10:37 AM on Monday, November 6th, 2023

Predictmedix AI Inc., a leading force in rapid health screening solutions driven by artificial intelligence (AI), marked a monumental moment at the D-30 event in New Delhi, India. This international summit, uniting 30 nations under the United Nations banner, signifies a pivotal step forward in the collective global fight against drug addiction and the ensuing disabilities it causes.

Predictmedix AI is at the forefront of leveraging AI technology to revolutionize health screening and remote patient care solutions worldwide. Their Safe Entry Stations, powered by proprietary AI, employ multispectral cameras to analyze physiological data patterns, predict vital parameters, and detect impairment, fatigue, or various mental health conditions.

Key Highlights and Advantages:

The introduction of Predictmedix AI’s Safe Entry Stations at the D-30 event unveiled a groundbreaking solution that has far-reaching implications for diverse environments. These stations provide rapid, non-invasive health assessments, including impairment detection, creating safer workplaces and communities.

Potential Impact and Significance:

The event in New Delhi served as a powerful platform for sharing knowledge and innovative solutions to combat drug addiction. Predictmedix AI’s participation and the introduction of Safe Entry Stations underscore their commitment to global well-being and their pivotal role in the fight against drug addiction and its associated disabilities.

Expert Opinions and Analysis:

Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix AI, emphasized the company’s mission to address pressing global health and safety concerns. He expressed honor in showcasing their Safe Entry Stations to representatives from 30 nations committed to promoting a safer world. Furthermore, the positive impact of this technology in education and skill development at a prominent institute in India opens another vertical for its application.

While the technology holds great promise, potential challenges in adoption and implementation may arise. Predictmedix AI is well-prepared to navigate these hurdles through strategic partnerships and ongoing innovation.

Predictmedix AI’s participation in the D-30 event is a testament to their pivotal role in combating drug addiction globally. The Safe Entry Stations represent a beacon of hope, providing a path towards a safer, drug-free world. With visionary leaders like Colonel G. Srikumar (Retd) at the helm, the company is poised to accelerate its impact not only in India but also in international markets, marking a significant milestone in Predictmedix AI’s journey towards global leadership in advanced AI technologies.

View Original Release: https://predictmedix.com/predictmedix-ai-unveils-safe-entry-stations-to-delegates-from-30-nations-at-d-30-event-in-new-delhi/

Predictmedix AI Revolutionizes Global Fight Against Drug Addiction with Cutting-Edge Screening Technology

Posted by Brittany McNabb at 9:48 AM on Thursday, November 2nd, 2023

Predictmedix AI Inc. has taken a significant stride in the global battle against drug addiction. The Toronto-based company, renowned for its rapid health screening solutions driven by proprietary artificial intelligence (AI), has been granted the distinguished honor of showcasing its groundbreaking impairment screening technology at the D-30 event. This summit, representing 30 nations united under the United Nations banner, is dedicated to combatting drug addiction on an international scale.

Predictmedix AI’s history is rooted in a commitment to innovation and excellence. Their impairment screening technology, a fusion of multispectral imaging and speech analysis, has achieved an impressive 90% accuracy rate in identifying impaired individuals. Powered by cutting-edge artificial intelligence, the system’s accuracy is set to soar as it continues to learn and adapt from new data.

Key Highlights and Advantages:

The technology’s impact extends beyond identification, delving into the real-time monitoring of vital parameters for patients recovering from drug addiction. This dual functionality for de-addiction treatment and managing associated disabilities holds immense promise for patients, students, and workers alike.

Potential Impact and Significance:

The participation in the D-30 event underscores Predictmedix AI’s commitment to innovation in the face of global challenges. By bringing together 30 nations, this summit amplifies the urgency and unity required to combat drug addiction effectively.

Expert Opinions and Analysis:

Dr. Rahul Kushwah, COO of Predictmedix AI, conveyed his enthusiasm for this opportunity, emphasizing the company’s dedication to leveraging innovation to combat drug addiction. The appointment of Colonel G. Srikumar (Retd), a distinguished veteran of the Indian Army, as the new director of Predictmedix India Pvt Ltd., further solidifies the company’s commitment to advancing its impact in India, Africa, and the Middle East.

Predictmedix AI’s invitation to the D-30 event stands as a testament to their pivotal role in combating drug addiction worldwide. Their impairment screening technology represents a beacon of hope, providing a path towards a safer, drug-free world. With Colonel Srikumar at the helm, the company is poised to accelerate its impact not only in India but also in international markets, marking a significant milestone in Predictmedix AI’s journey towards global leadership in advanced AI technologies.

View Original Release: https://www.accesswire.com/798717/predictmedix-ai-showcases-innovative-impairment-screening-technology-at-a-30-country-summit-in-india-focusing-on-combating-drug-addiction-globally

Predictmedix AI: Leading the Charge in Sustainable Healthcare and Workplace Safety

Posted by Brittany McNabb at 4:43 PM on Tuesday, October 10th, 2023

In an era where sustainability has become a paramount concern for businesses across industries, one area that often takes precedence is healthcare and workplace safety. Predictmedix AI, a Toronto-based health tech company, is not only redefining the landscape of healthcare but is also at the forefront of creating sustainable, cutting-edge solutions for the industry.

Sustainability: More Than Environmental Concerns

While sustainability is frequently associated with environmental initiatives, it extends far beyond that. In the healthcare sector, sustainability encompasses optimizing resources, reducing waste, enhancing efficiency, and most importantly, improving patient care. Predictmedix AI embraces this comprehensive view of sustainability, aiming to revolutionize how we approach healthcare and workplace safety.

Contactless Innovation: A Sustainable Approach

One of the key tenets of Predictmedix AI’s innovation is its commitment to contactless solutions. The company’s Safe Entry Stations utilize advanced AI and multispectral imaging to conduct non-invasive screenings. This approach not only enhances patient and employee safety but also minimizes the use of resources associated with traditional screening methods, such as disposable supplies and extensive cleaning protocols.

 Efficiency in Triage: Enhancing Patient Care

Predictmedix AI’s comprehensive triage solution is a game-changer for high-traffic hospitals, particularly in targeted Asian markets. By leveraging AI-driven technology, hospitals can significantly reduce the time patients spend in triage. This not only leads to better patient outcomes but also optimizes resource allocation, making healthcare delivery more sustainable and efficient.

 Strategic Partnerships: Fostering Innovation

Collaboration is a cornerstone of sustainability, and Predictmedix AI understands this well. Through strategic partnerships with institutions like the Indian Institute of Technology (IIT) and Max Healthcare, the company is fostering an environment of innovation. By combining expertise and resources, these collaborations are driving forward sustainable solutions that have the potential to revolutionize the healthcare landscape.

Global Impact: Deploying Technology Where it’s Needed

Predictmedix AI’s technology has been deployed at major events, forums, and clinical trials worldwide. This global reach signifies the company’s dedication to making a tangible impact on a global scale. By addressing healthcare and workplace safety challenges across different regions, Predictmedix AI is contributing to a more sustainable and resilient healthcare ecosystem. 

Market Potential: Sustained Growth in a Growing Industry

With an estimated market potential of $26.7 billion USD by 2027, Predictmedix AI is positioned for sustained growth. This not only highlights the financial viability of the company but also underscores the increasing recognition of the importance of sustainable healthcare solutions.

 A Sustainable Future with Predictmedix AI

As the healthcare and workplace safety landscape evolves, Predictmedix AI stands as a beacon of innovation and sustainability. By embracing contactless solutions, optimizing triage processes, fostering strategic collaborations, and making a global impact, the company is not only redefining healthcare but is also leading the charge in sustainable practices for the industry. With a market poised for substantial growth, Predictmedix AI is well on its way to creating a sustainable future for healthcare and workplace safety.

 

YOUR NEXT STEPS 

Visit $PMED HUB On AGORACOM: https://agoracom.com/ir/Predictmedixhttps 

Visit $PMED 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Predictmedix/profile

Visit $PMED Official Verified Discussion Forum On AGORACOM: https://agoracom.com/ir/Predictmedix/forums/discussion

Watch $PMED Videos On AGORACOM YouTube Channel:

https://www.youtube.com/feed/library

 

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit  https://agoracom.com/terms-and-conditions

Predictmedix $PMED.ca $PMEDF Announces Technology Deployments at Major Office Towers in Calgary and Edmonton in Partnership With Aspen Properties $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 9:51 AM on Monday, April 19th, 2021
PMED PredictMedix

TORONTO, April 19, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce deployment of Safe Entry Stations at 4 key office towers in downtown Calgary and Edmonton in partnership with Apsen Properties and Juiceworks Exhibits (Juiceworks).

Calgary’s The Edison, Palliser Complex, The Ampersand and Edmonton’s Bell Tower are raising the bar by providing a completely voluntary infectious disease symptom screening option for their tenants. This is a multi-unit, 24 month contract.

Safe Entry Stations are powered by artificial intelligence (AI).  Military-grade multispectral cameras use thermal imaging and a proprietary hardware configuration to capture data patterns that are analyzed instantly.

They provide an immediate assessment of individuals looking to access shared spaces by screening for multiple symptoms associated with infectious diseases, such as COVID-19. Moreover, the technology is 100% non-invasive, expediting the screening process even at high volume locations.

This ground-breaking technology is poised to change the way we look at the screening and diagnosis of infectious diseases. Our autonomous, comprehensive AI algorithms are continuously evolving via machine learning, are deployed instantly on the cloud, and deliver a multi-symptom analysis within seconds.

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/759282-predictmedix-announces-technology-deployments-at-major-office-towers-in-calgary-and-edmonton-in-partnership-with-aspen-properties/messages/2312537#message

Predictmedix $PMED.ca $PMEDF Announces a 2-Year Revenue Contract With Flow Alkaline Spring Water for North American Operations $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 10:49 AM on Wednesday, April 14th, 2021
PMED PredictMedix

TORONTO, April 14, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a 24 month, multi-unit contract to deploy Safe Entry Stations throughout the North American operations of Flow Water Inc. (“Flow Alkaline Spring Water” or “Flow”). The partnership marks the successful completion of our initial pilot, as the technology is now scaled and deployed across all of Flow’s operations both in Canada and the USA.

A pioneer in the health and wellness arena, Flow was one of the first in Eastern Canada to partner with Predictmedix and Juiceworks Exhibits (JUICEWORKS) to implement Safe Entry Stations at their Aurora facilities in August 2020. North America’s first socially responsible artisan alkaline water plant, Flow continues its spirit of innovation by incorporating AI-powered solutions to improve operational efficiencies.

Initially deployed as a beta site, Safe Entry quickly became an integral part of Flow’s health and safety protocol. The autonomous nature of the technology and the robust multi-symptom screening imparted an added sense of security among their workforce.

As part of their ongoing commitment to their valued staff, they have entered into a multi-unit revenue contract for two years and will now be expanding the program to their remaining facilities in Aurora, Ontario and Verona, Virginia.

“Implementing Safe Entry at our plants has dramatically decreased our absenteeism and increased employee peace of mind. Keeping our staff safe is top priority, and as such, we were determined to implement the best available solution, which we found in Safe Entry,” affirms Nicholas Reichenbach, Founder & Executive Chairman of Flow.

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/759031-predictmedix-announces-a-2-year-revenue-contract-with-flow-alkaline-spring-water-for-north-american-operations/messages/2311881#message

Predictmedix $PMED.ca $PMEDF and JUICEWORKS Form Strategic Partnership with CONNECTUS Global to Deploy Safe Entry Stations Nationwide $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM at 9:09 AM on Monday, April 5th, 2021
PMED PredictMedix

TORONTO, April 05, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a partnership to deploy Safe Entry Stations in partnership with North American industry leaders JUICEWORKS EXHIBITS (JUICEWORKS) and CONNECTUS Global.

SAFE ENTRY STATIONS leverage military-grade multispectral cameras paired with Predictmedix’s proprietary, clinically based artificial intelligence algorithms. They provide an immediate assessment of individuals looking to access shared spaces by checking for multiple symptoms associated with infectious diseases such as COVID-19.

This ground-breaking technology is poised to change the way we look at screening and, eventually, the diagnosis of infectious diseases. Autonomous, comprehensive analysis provides peace of mind to individuals entering shared spaces, be it for work, entertainment, or necessity.

Mike Anderson, CEO of CONNECTUS Global, commented:

“Seeing this level of innovation is exciting to drive adoption of digital processes throughout the public and private sectors, what PREDICTMEDIX and JUICEWORKS are doing is revolutionary to introduce a new level of health measurement into the community.”

Read More: https://agoracom.com/ir/Predictmedix/forums/discussion/topics/758511-predictmedix-and-juiceworks-form-strategic-partnership-with-connectus-global-to-deploy-safe-entry-stations-nationwide/messages/2310850#message